# Capricor Therapeutics, Inc.: filings

CAPR · Nasdaq · CIK 1133869 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/capr.md) · [Financials](/companies/capr/financials.md) · [Filings](/companies/capr/filings.md) · [Insiders](/companies/capr/insiders.md)

## Reports and events: 337 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 268, 8-K 212, 10-Q 53, 3 29, UPLOAD 20, 424B5 19, CORRESP 19, 10-K 18, EFFECT 18, 424B3 17, DEF 14A 17, S-3 11, S-8 11, SC 13D/A 11, CT ORDER 10, SC 13G 9, SC 13G/A 9, 8-K/A 8, D 8, SCHEDULE 13G 7, 5 6, PRE 14A 6, SC 13D 6, SCHEDULE 13G/A 6, 144 5, ARS 5, S-1 5, S-1/A 3, S-3/A 3, 10-K/A 2, 10-Q/A 2, 3/A 2, 4/A 2, 8-A12B 2, POS AM 2, 144/A 1, 15-12B 1, 25-NSE 1, 424B4 1, CERTNAS 1, FWP 1, NT 10-K 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-24 | 13:25 ET | [8-K](/filings/0001104659-26-100071.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-100071 |
| 2026-08-14 | 20:46 ET | [10-Q](/filings/0001104659-26-097294.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097294 |
| 2026-08-13 | 20:07 ET | [8-K](/filings/0001104659-26-095908.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095908 |
| 2026-07-30 | 20:05 ET | [8-K](/filings/0001104659-26-088667.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088667 |
| 2026-07-29 | 14:05 ET | [8-K](/filings/0001104659-26-087891.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-087891 |
| 2026-07-14 | 21:06 ET | [8-K](/filings/0001104659-26-083559.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-26-083559 |
| 2026-06-26 | 21:15 ET | [8-K](/filings/0001104659-26-078327.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-078327 |
| 2026-06-08 | 20:05 ET | [8-K](/filings/0001104659-26-071364.md) | 5.07 Shareholder vote results | 0001104659-26-071364 |
| 2026-05-13 | 21:20 ET | [10-Q](/filings/0001104659-26-060382.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060382 |
| 2026-05-12 | 20:06 ET | [8-K](/filings/0001104659-26-059380.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059380 |
| 2026-05-07 | 20:40 ET | [8-K](/filings/0001104659-26-057221.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057221 |
| 2026-04-10 | 20:31 ET | [DEF 14A](/filings/0001104659-26-042070.md) | Proxy statement, period 2026-06-04 | 0001104659-26-042070 |
| 2026-03-17 | 21:00 ET | [10-K](/filings/0001104659-26-029580.md) | Annual report, period 2025-12-31 | 0001104659-26-029580 |
| 2026-03-12 | 20:01 ET | [8-K](/filings/0001104659-26-027037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-027037 |
| 2026-03-10 | 15:01 ET | [8-K](/filings/0001104659-26-025657.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-025657 |
| 2025-12-05 | 22:07 ET | [8-K](/filings/0001104659-25-118934.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-118934 |
| 2025-12-03 | 14:29 ET | [8-K](/filings/0001104659-25-117981.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-117981 |
| 2025-12-03 | 12:21 ET | [8-K](/filings/0001104659-25-117947.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117947 |
| 2025-11-10 | 22:20 ET | [10-Q](/filings/0001104659-25-109298.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109298 |
| 2025-11-10 | 21:01 ET | [8-K](/filings/0001104659-25-109119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109119 |
| 2025-08-11 | 21:25 ET | [10-Q](/filings/0001558370-25-011084.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011084 |
| 2025-08-11 | 20:06 ET | [8-K](/filings/0001558370-25-011047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011047 |
| 2025-07-11 | 10:35 ET | [8-K](/filings/0001558370-25-009186.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009186 |
| 2025-05-27 | 13:15 ET | [8-K](/filings/0001558370-25-008145.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001558370-25-008145 |
| 2025-05-14 | 20:30 ET | [10-Q](/filings/0001558370-25-007770.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007770 |
| 2025-05-13 | 20:06 ET | [8-K](/filings/0001558370-25-007574.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007574 |
| 2025-04-08 | 21:15 ET | [DEF 14A](/filings/0001558370-25-004610.md) | Proxy statement, period 2025-05-22 | 0001558370-25-004610 |
| 2025-04-08 | 21:00 ET | [8-K](/filings/0001558370-25-004605.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-004605 |
| 2025-03-26 | 20:15 ET | [10-K](/filings/0001558370-25-003707.md) | Annual report, period 2024-12-31 | 0001558370-25-003707 |
| 2025-03-19 | 20:13 ET | [8-K](/filings/0001558370-25-003304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003304 |
| 2025-03-04 | 12:05 ET | [8-K](/filings/0001558370-25-002097.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002097 |
| 2025-01-02 | 19:17 ET | [8-K](/filings/0001558370-25-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000010 |
| 2024-11-14 | 21:30 ET | [10-Q](/filings/0001558370-24-015730.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015730 |
| 2024-11-13 | 21:02 ET | [8-K](/filings/0001558370-24-015519.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015519 |
| 2024-10-17 | 10:01 ET | [8-K](/filings/0001558370-24-013357.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013357 |
| 2024-10-16 | 20:25 ET | [8-K](/filings/0001558370-24-013344.md) | 2.02 Results of operations; 8.01 Other events | 0001558370-24-013344 |
| 2024-10-09 | 13:16 ET | [8-K](/filings/0001558370-24-013207.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013207 |
| 2024-09-24 | 20:01 ET | [8-K](/filings/0001558370-24-012983.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-012983 |
| 2024-09-17 | 13:15 ET | [8-K](/filings/0001558370-24-012836.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-012836 |
| 2024-08-08 | 21:00 ET | [10-Q](/filings/0001558370-24-011638.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011638 |
| 2024-08-07 | 20:06 ET | [8-K](/filings/0001558370-24-011350.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011350 |
| 2024-05-15 | 21:05 ET | [8-K](/filings/0001558370-24-008313.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-24-008313 |
| 2024-05-15 | 21:00 ET | [8-K](/filings/0001558370-24-008310.md) | 5.07 Shareholder vote results | 0001558370-24-008310 |
| 2024-05-14 | 13:00 ET | [10-Q](/filings/0001558370-24-008072.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008072 |
| 2024-05-13 | 20:05 ET | [8-K](/filings/0001558370-24-007958.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007958 |
| 2024-04-29 | 13:25 ET | [8-K](/filings/0001558370-24-006020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006020 |
| 2024-04-01 | 21:35 ET | [DEF 14A](/filings/0001558370-24-004399.md) | Proxy statement, period 2024-05-14 | 0001558370-24-004399 |
| 2024-03-11 | 12:30 ET | [10-K](/filings/0001558370-24-002861.md) | Annual report, period 2023-12-31 | 0001558370-24-002861 |
| 2024-02-29 | 21:06 ET | [8-K](/filings/0001558370-24-002183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-002183 |
| 2024-01-11 | 14:00 ET | [8-K](/filings/0001558370-24-000197.md) | 8.01 Other events | 0001558370-24-000197 |

Page 1 of 7. [Older](/companies/capr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.